Clinical Trial Opportunity for Triple-Negative Breast Cancer
| Date | Form | Description | XBRL | Pages |
|---|---|---|---|---|
| 11/03/22 | 10-Q | Form 10-Q: Quarterly report pursuant to Section 13 or 15(d) |
|
33 |
| 11/03/22 | 8-K | Form 8-K: Current report filing |
|
5 |
| 11/03/22 | SC 13G/A | Form SC 13G/A: Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions | 7 | |
| 10/25/22 | 8-K | Form 8-K: Current report filing |
|
77 |
| 10/25/22 | SC 13G | Form SC 13G: Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions | 17 | |
| 10/24/22 | 424B5 | Form 424B5: Prospectus filed pursuant to Rule 424(b)(5) | 36 | |
| 10/20/22 | 424B5 | Form 424B5: Prospectus filed pursuant to Rule 424(b)(5) | 1 | |
| 09/22/22 | 8-K | Form 8-K: Current report filing |
|
4 |
| 09/13/22 | 8-K | Form 8-K: Current report filing |
|
4 |
| 08/05/22 | S-8 | Form S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans | 7 |
- Previous Page
- Page 1
- …
- Page 16
- Page 17
- Page 18
- Page 19
- Page 20
- Page 21
- Page 22
- Page 23
- Page 24
- Page 25
- …
- Page 120
- Next Page